A Phase 1 interventional study of Conventional glass ionomer and Nano hydroxyapatite reinforced glass ionomer in Dental Restoration Failure, sponsored by Cairo University. Status unknown at 1 site in Egypt. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-01-08.
Sponsored by Cairo University · Phase 1, Interventional, and Treatment
In geriatric patients, will the clinical performance of nano hydroxyapatite reinforced glass ionomer be better than conventional glass ionomer cement in treatment of root caries lesions over one year follow up?
Glass carbomers are commercialized under the name of GCP Glass Fill, this material may be an interesting subject of research, certainly its bioactive properties as the manufacturer claims this material to have remineralizing properties. If this is the case, GCP Glass Fill could be an interesting reference material for further bioactivity studies
≥ 50 years old
Exclusion Criteria:
Patients younger than 50 years old
Nano hydroxyapatite Reinforced Glass Ionomer that results in chemical bond formation with tooth structure mimic that of enamel tissue
Drug: Nano hydroxyapatite reinforced glass ionomer
Conventional Glass Ionomer cement fluoride-releasing restorative system that combines fluoride release of glass ionomer cement and acceptable esthetics, a wear resistant, self-adhesive
Drug: Conventional glass ionomer
Conventional glass ionomer with enhanced mechanical and esthetic proberties
Also known as: Fujiix gc corporation
Nanohydroxyapatite reinforced glass ionomer restorative material with enhanced mechanical proberties and chemical adhesion to tooth structure
Also known as: Glass carbomer
Clinical restorative performance Service (USHPS)
Change in the clinical behavior of the restoration (e.g. anatomical contour, shade match, secondary caries) using modified United State Public Health clinical evaluation assessment method Service (USHPS)
Time frame: Change from the baseline at 3, 6 and12 months
Plan to share: Yes
Supporting information: Study protocol
No publications or documents are linked to this record.
This study is status unknown, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University